← Evidence map

ArticleFrontiers in oncology2026

Case Report: Synergistic potential of RANKL and ACLY inhibition in a breast cancer patient with acquired resistance to CDK4/6 inhibitors.

Anastasiia Samusieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Case Report: Synergistic potential of RANKL and ACLY inhibition in a breast cancer patient with acquired resistance to CDK4/6 inhibitors. | OpenQuestion